HK1257427A1 - 用於製備2-吡唑並[1，5-a]吡嗪-2-基吡啶並[1，2-a]嘧啶-4-酮的方法 - Google Patents

用於製備2-吡唑並[1，5-a]吡嗪-2-基吡啶並[1，2-a]嘧啶-4-酮的方法

Info

Publication number
HK1257427A1
HK1257427A1 HK18116638.4A HK18116638A HK1257427A1 HK 1257427 A1 HK1257427 A1 HK 1257427A1 HK 18116638 A HK18116638 A HK 18116638A HK 1257427 A1 HK1257427 A1 HK 1257427A1
Authority
HK
Hong Kong
Prior art keywords
ylpyrido
pyrazin
pyrazolo
pyrimidin
preparation
Prior art date
Application number
HK18116638.4A
Other languages
English (en)
Inventor
帕斯卡·多特
費邊·費元
斯特凡·希爾德布蘭德
烏爾蘇拉·霍夫曼
法比安·霍夫曼-埃默里
羅蘭·邁耶
杰勒德·梅因
潘卡吉·雷杰
喬治·烏伊特希克
Original Assignee
豪夫邁‧羅氏有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 豪夫邁‧羅氏有限公司 filed Critical 豪夫邁‧羅氏有限公司
Publication of HK1257427A1 publication Critical patent/HK1257427A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK18116638.4A 2016-04-28 2018-12-27 用於製備2-吡唑並[1，5-a]吡嗪-2-基吡啶並[1，2-a]嘧啶-4-酮的方法 HK1257427A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16167494 2016-04-28
PCT/EP2017/059714 WO2017186668A1 (en) 2016-04-28 2017-04-25 A process for the preparation of 2-pyrazolo[1,5-a]pyrazin-2-ylpyrido[1,2-a]pyrimidin-4-one

Publications (1)

Publication Number Publication Date
HK1257427A1 true HK1257427A1 (zh) 2019-10-18

Family

ID=55860726

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18116638.4A HK1257427A1 (zh) 2016-04-28 2018-12-27 用於製備2-吡唑並[1，5-a]吡嗪-2-基吡啶並[1，2-a]嘧啶-4-酮的方法

Country Status (6)

Country Link
US (1) US10538536B2 (zh)
EP (1) EP3448861B1 (zh)
JP (1) JP6983813B2 (zh)
CN (1) CN108473510B (zh)
HK (1) HK1257427A1 (zh)
WO (1) WO2017186668A1 (zh)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR039774A1 (es) * 2002-05-01 2005-03-02 Wyeth Corp 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas
DE102007032349A1 (de) * 2007-07-11 2009-01-15 Bayer Healthcare Ag Imidazo-, Pyrazolopyrazine und Imidazotriazine und ihre Verwendung
US9073927B2 (en) * 2010-01-22 2015-07-07 Fundacion Centro Nacional De Investigaciones Oncologicas Carlos Iii Inhibitors of PI3 kinase
SG185462A1 (en) * 2010-05-07 2012-12-28 Gilead Connecticut Inc Pyridone and aza-pyridone compounds and methods of use
CN102134234B (zh) * 2011-01-18 2013-06-05 南京工业大学 吲唑脲类化合物及其制法和药物用途
GB201116559D0 (en) * 2011-09-26 2011-11-09 Univ Leuven Kath Novel viral replication inhibitors
UA111756C2 (uk) * 2011-11-03 2016-06-10 Ф. Хоффманн-Ля Рош Аг Сполуки гетероарилпіридону та азапіридону як інгібітори тирозинкінази брутона
BR112014019750B1 (pt) 2012-02-10 2020-03-03 F. Hoffmann-La Roche Ag. Composto, composição farmacêutica e seus usos
WO2014044846A1 (en) * 2012-09-24 2014-03-27 Evotec (Uk) Ltd. 3-(aryl- or heteroaryl-amino)-7-(3,5-dimethoxyphenyl)isoquinoline derivatives as fgfr inhibitors useful for the treatment of proliferative disorders or dysplasia
WO2014200882A1 (en) * 2013-06-11 2014-12-18 Janssen Pharmaceutica Nv PDE10a INHIBITORS FOR THE TREATMENT OF TYPE II DIABETES
EP3029031A4 (en) * 2013-07-30 2017-01-11 Takeda Pharmaceutical Company Limited Heterocyclic compound
MX2016001963A (es) * 2013-08-19 2016-05-26 Hoffmann La Roche Metodo de seleccion.
JP2015054838A (ja) * 2013-09-12 2015-03-23 興和株式会社 血中ｌｄｌコレステロールを低下させる医薬
EP3082820B1 (en) * 2013-12-19 2022-07-20 PTC Therapeutics, Inc. Methods for modulating the amount of rna transcripts
CN105294655B (zh) * 2014-07-26 2019-03-15 广东东阳光药业有限公司 Cdk类小分子抑制剂的化合物及其用途

Also Published As

Publication number Publication date
EP3448861A1 (en) 2019-03-06
JP6983813B2 (ja) 2021-12-17
CN108473510B (zh) 2021-10-29
WO2017186668A1 (en) 2017-11-02
EP3448861B1 (en) 2021-04-21
US10538536B2 (en) 2020-01-21
CN108473510A (zh) 2018-08-31
US20190144468A1 (en) 2019-05-16
JP2019514926A (ja) 2019-06-06

Similar Documents

Publication Publication Date Title
IL266170A (en) A process for the preparation of pyrazolo[1,5-a]pyrimidines and their salts
HK1258157A1 (zh) 作為jak抑制劑的吡唑並[1，5-a]吡嗪-4-基衍生物
IL277576A (en) Mutated pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
IL265918A (en) Pyrazolo [1,5– A] compounds Pyridine is converted as RET kinase inhibitors
HK1256751A1 (zh) [1，2，4]三唑並[1，5-a]嘧啶-7-基化合物
EP3452481A4 (en) IMIDAZO [1,2-B] SUBSTITUTED PYRIDAZINES, IMIDAZO [1,5-B] SUBSTITUTED PYRIDAZINES, RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL CONDITIONS
IL262673A (en) Pyrazolo[1,5-a]pyrimidine compound
ZA201605666B (en) Pyrazolo[1,5-a]pyrimidines as antiviral compounds
EP3472169A4 (en) PROCESS FOR PREPARING 4-CHLORO-7H-PYRROLO [2,3-D] PYRIMIDINE
IL290419B (en) Imidazo[a-1,5]pyrazine derivatives as inhibitors of pi3k delta
HK1259613A1 (zh) 新型5h-吡咯並[2，3-d]嘧啶-6(7h)-酮衍生物
ZA201804871B (en) Process for preparing 7h-pyrrolo [2, 3-d] pyrimidine compounds
HK1254651A1 (zh) 吡唑並[1，5-a]嘧啶-3-甲酰胺的環醚衍生物
HK1257427A1 (zh) 用於製備2-吡唑並[1，5-a]吡嗪-2-基吡啶並[1，2-a]嘧啶-4-酮的方法
EP3227292A4 (en) 4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUNDS
AU2014904868A0 (en) 4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUNDS